No Data
No Data
Express News | GSK Says First Single-Dose Medicine To Prevent Relapse Of P. Vivax Malaria Launched In Thailand And Brazil
Express News | UPDATE: Circulations Of Report Titled 'FDA To Evaluate Potential Risk Of Neural Tube Birth Defects With HIV Medicine Dolutegravir (Juluca, Tivicay, Triumeq)' Was Originally Issued On September 6, 2018.; Shares Of GSK See Rebound From Lows
What the U.K. Election Means for Oil Stocks and Other Sectors -- Barrons.com
By Brian Swint U.K. voters gave the biggest election victory to the Labour Party since former Prime Minister Tony Blair's landslide win in 1997. If history is anything to go by, that could be a boon
Express News | 'FDA to Evaluate Potential Risk of Neural Tube Birth Defects With HIV Medicine Dolutegravir (Juluca, Tivicay, Triumeq)' - FDA
Markets Like Certainty. How the Biden and Trump Show Is Affecting Stocks, Bonds.
GSK's RSV Vaccine Sales Outlook Dims After CDC's Narrowed Recommendation -- Market Talk
0619 GMT - GSK's sales outlook for its respiratory syncytial virus vaccine, Arexvy, could take a blow after U.S. health officials narrowed their age recommendation for RSV shots last week, Citi analys
Jason Brownz : sell all going to 30
Mr Value investorOP Jason Brownz: Ohh I see. Do you know what is wrong!
MARKET-TEST-DUMMY Jason Brownz: I was hoping to see turn around maybe 37ish